Antibody tests for identification of current and past infection with SARS‐CoV‐2
T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Advances in biosensors and diagnostic technologies using nanostructures and nanomaterials
Nanoscale materials have unique properties that make them especially useful for
biomedical diagnostic applications. Recent developments in nanoengineering have resulted …
biomedical diagnostic applications. Recent developments in nanoengineering have resulted …
COVID-19 antibody tests and their limitations
G Liu, JF Rusling - ACS sensors, 2021 - ACS Publications
COVID-19, caused by the SARS-CoV-2 virus, has developed into a global health crisis,
causing over 2 million deaths and changing people's daily life the world over. Current main …
causing over 2 million deaths and changing people's daily life the world over. Current main …
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
Accurate serological assays to detect antibodies to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
A Padoan, F Bonfante, M Pagliari, A Bortolami… - …, 2020 - thelancet.com
Background Reliable high-throughput serological assays for SARS-CoV-2 antibodies are
urgently needed for the effective containment of the COVID-19 pandemic, as it is of crucial …
urgently needed for the effective containment of the COVID-19 pandemic, as it is of crucial …
[HTML][HTML] COVID-19 convalescent plasma composition and immunological effects in severe patients
Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the
composition and mechanism of action are not fully known. Therefore, we undertook a two …
composition and mechanism of action are not fully known. Therefore, we undertook a two …
Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects
Abstract Coronavirus disease 2019 (COVID-19) pandemic is currently a serious global
health threat. While conventional laboratory tests such as quantitative real-time polymerase …
health threat. While conventional laboratory tests such as quantitative real-time polymerase …
A comparative review of immunoassays for COVID-19 detection
Introduction: The gold standard for diagnosis of coronavirus disease 2019 (COVID-19) is
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
Insights into household transmission of SARS-CoV-2 from a population-based serological survey
Understanding the risk of infection from household-and community-exposures and the
transmissibility of asymptomatic infections is critical to SARS-CoV-2 control. Limited previous …
transmissibility of asymptomatic infections is critical to SARS-CoV-2 control. Limited previous …
One-year sustained cellular and humoral immunities in coronavirus disease 2019 (COVID-19) convalescents
J Zhang, H Lin, B Ye, M Zhao, J Zhan… - Clinical Infectious …, 2022 - academic.oup.com
Background The longitudinal antigen-specific immunity in COVID-19 convalescents is
crucial for long-term protection upon individual re-exposure to SARS-CoV-2, and even more …
crucial for long-term protection upon individual re-exposure to SARS-CoV-2, and even more …